Press release

09 Nov, 2017  ·  Regulatory information

Cantargia: Combined directed issue and fully guaranteed rights issue of 232 MSEK for its expanded clinical program of immuno-oncology antibody CAN04

Read the press release here: https://cantargia.com/en/investors/shareoffering